IL114542A0 - Use of muramyl peptide compounds - Google Patents
Use of muramyl peptide compoundsInfo
- Publication number
- IL114542A0 IL114542A0 IL11454295A IL11454295A IL114542A0 IL 114542 A0 IL114542 A0 IL 114542A0 IL 11454295 A IL11454295 A IL 11454295A IL 11454295 A IL11454295 A IL 11454295A IL 114542 A0 IL114542 A0 IL 114542A0
- Authority
- IL
- Israel
- Prior art keywords
- peptide compounds
- muramyl peptide
- muramyl
- compounds
- peptide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9413935A GB9413935D0 (en) | 1994-07-11 | 1994-07-11 | Use of maramyl peptide compounds |
| CN95194573A CN1155245A (en) | 1994-07-11 | 1995-07-10 | Use of muramyl peptide compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL114542A0 true IL114542A0 (en) | 1995-11-27 |
Family
ID=25743816
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL11454295A IL114542A0 (en) | 1994-07-11 | 1995-07-11 | Use of muramyl peptide compounds |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0768888A1 (en) |
| JP (1) | JPH10505580A (en) |
| CN (1) | CN1155245A (en) |
| AU (1) | AU2893595A (en) |
| BG (1) | BG101126A (en) |
| CA (1) | CA2194678A1 (en) |
| CZ (1) | CZ4797A3 (en) |
| GB (1) | GB9413935D0 (en) |
| HU (1) | HUT77290A (en) |
| IL (1) | IL114542A0 (en) |
| SK (1) | SK2697A3 (en) |
| WO (1) | WO1996001645A1 (en) |
| ZA (1) | ZA955763B (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998046251A1 (en) * | 1997-04-11 | 1998-10-22 | Oleg Vitalievich Kaljuzhin | Immunomodulator and pharmaceutical compositions with antitumor properties, and a food additive |
| GB9710351D0 (en) * | 1997-05-20 | 1997-07-16 | Scotia Holdings Plc | Glucosamine fatty acids |
| WO1999062537A1 (en) * | 1998-06-04 | 1999-12-09 | The Rockefeller University | Methods and agents for modulating the immune response and inflammation involving monocyte and dendritic cell membrane proteins |
| DE10106852A1 (en) * | 2001-02-14 | 2002-09-05 | T Luger | Anti-inflammatory compounds |
| FR2899466B1 (en) * | 2006-04-07 | 2008-09-26 | Oreal | USE OF C-GLYCOSIDE COMPOUND ACTIVATING AGENT AND REGULATOR OF SKIN IMMUNITY |
| WO2008048076A1 (en) | 2006-10-20 | 2008-04-24 | Amorepacific Corporation | A composition for treatment of atopic dermatitis comprising glucosamine and derivatives thereof and a method for treatment of atopic dermatitis using them |
| US8603978B2 (en) * | 2006-12-01 | 2013-12-10 | The United States of America, as represented by the Secretary, Department of Health and Humand Services | Use of muramyl dipeptide (MDP) for treating inflammation |
| FR2933984B1 (en) * | 2008-07-15 | 2013-01-04 | Univ Bourgogne | D, D MURAMYLDIPEPTIDE, DERIVATIVE COMPOUNDS AND USE FOR THE TREATMENT OF ATHEROMOUS PLAQUES |
| US10610564B2 (en) | 2015-02-26 | 2020-04-07 | Stc.Unm | IRGM and precision autophagy controls for antimicrobial and inflammatory disease states and methods of detection of autophagy |
| ES2930246T3 (en) | 2015-12-10 | 2022-12-09 | Bharat Biotech Int Ltd | New compound derived from muramyl peptide, synthesis and uses thereof |
| EP3389643B1 (en) | 2015-12-15 | 2023-05-03 | Bharat Biotech International Limited | Novel muramyl peptide derivative compound, synthesis and uses thereof |
| EP4308105A1 (en) | 2021-03-19 | 2024-01-24 | Trained Therapeutix Discovery, Inc. | Compounds for regulating trained immunity, and their methods of use |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4357322A (en) * | 1980-07-29 | 1982-11-02 | Syntex (U.S.A.) Inc. | Method of preventing, reducing or inhibiting inflammation |
| US4698330A (en) * | 1983-06-27 | 1987-10-06 | President & Fellows Of Harvard College | Somnogenic compositions and method of use |
| HU205147B (en) * | 1989-06-29 | 1992-03-30 | Sandoz Ag | Process for producing muramyl dipeptide derivative and pharmaceutical compostions comprising same |
| EP0615522B1 (en) * | 1991-11-19 | 1999-09-22 | Peptech (Uk) Limited | Muramyl compounds for treatment of septic shock |
| GB9204354D0 (en) * | 1992-02-28 | 1992-04-08 | Biokine Tech Ltd | Compounds for medicinal use |
| GB9320820D0 (en) * | 1993-10-08 | 1993-12-01 | Biokine Tech Ltd | Compounds for medicinal use |
| GB9326518D0 (en) * | 1993-12-29 | 1994-03-02 | Sandoz Ltd | Organic compounds |
-
1994
- 1994-07-11 GB GB9413935A patent/GB9413935D0/en active Pending
-
1995
- 1995-07-10 AU AU28935/95A patent/AU2893595A/en not_active Abandoned
- 1995-07-10 EP EP95924437A patent/EP0768888A1/en not_active Withdrawn
- 1995-07-10 WO PCT/GB1995/001619 patent/WO1996001645A1/en not_active Application Discontinuation
- 1995-07-10 CN CN95194573A patent/CN1155245A/en active Pending
- 1995-07-10 JP JP8504191A patent/JPH10505580A/en active Pending
- 1995-07-10 SK SK26-97A patent/SK2697A3/en unknown
- 1995-07-10 CA CA002194678A patent/CA2194678A1/en not_active Abandoned
- 1995-07-10 CZ CZ9747A patent/CZ4797A3/en unknown
- 1995-07-10 HU HU9700071A patent/HUT77290A/en unknown
- 1995-07-11 ZA ZA955763A patent/ZA955763B/en unknown
- 1995-07-11 IL IL11454295A patent/IL114542A0/en unknown
-
1997
- 1997-01-10 BG BG101126A patent/BG101126A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CZ4797A3 (en) | 1997-07-16 |
| HUT77290A (en) | 1998-03-30 |
| BG101126A (en) | 1997-09-30 |
| JPH10505580A (en) | 1998-06-02 |
| ZA955763B (en) | 1997-01-13 |
| GB9413935D0 (en) | 1994-08-31 |
| AU2893595A (en) | 1996-02-09 |
| SK2697A3 (en) | 1997-08-06 |
| WO1996001645A1 (en) | 1996-01-25 |
| HU9700071D0 (en) | 1997-02-28 |
| CA2194678A1 (en) | 1996-01-25 |
| CN1155245A (en) | 1997-07-23 |
| EP0768888A1 (en) | 1997-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB9421709D0 (en) | Therapeutic compounds | |
| PL318062A1 (en) | Therapeutic compounds | |
| GB9526560D0 (en) | Use of 2-Amino-Heterocycles | |
| IL113248A0 (en) | Use of alpha - 1c specific compounds | |
| EP0752873A4 (en) | Labelled peptide compounds | |
| ZA955763B (en) | Use of muramyl peptide compounds | |
| GB9418762D0 (en) | Use of substituted cyclopentane-DI-and-triones | |
| ZA959517B (en) | Leutherobin and analogs thereof | |
| IL113992A0 (en) | Use of copolymer-1 | |
| SG42329A1 (en) | Use of phenylcyclohexylcarboxamides | |
| ZA957997B (en) | Use of muramyl peptide compounds | |
| GB9506372D0 (en) | New peptide compounds | |
| GB9413751D0 (en) | Immunodominant peptides | |
| ZA978027B (en) | The use of muramyl peptides | |
| GB9411594D0 (en) | Demagnetisation of materials | |
| NZ295530A (en) | Preparation of 1-halo-3-trialkylsilanyl-benzenes | |
| GB9422764D0 (en) | Use of compound | |
| GB9424408D0 (en) | New peptide compounds | |
| IL118225A0 (en) | Use of felodipine | |
| GB9418295D0 (en) | Preparation of indoloquinone compounds | |
| GB9722026D0 (en) | Use of compounds | |
| GB9414971D0 (en) | Preparation of thionucleosides | |
| HU9403029D0 (en) | Praess for preparation of n-methoxy-acetyl-anilines | |
| GB9510042D0 (en) | New peptide compounds | |
| GB9504891D0 (en) | New peptide compounds |